Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

11.30
Delayed Data
As of Dec 08
 +0.10 / +0.89%
Today’s Change
6.00
Today|||52-Week Range
12.98
+8.03%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 17.00, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +50.44% increase from the last price of 11.30.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$11.7M
Reporting Date
Feb 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -154.73%
 
 
 
 
 
 
Growthannually 78.18%
 
 
 
 
 
 

Sales

Growthquarterly -80.25%
 
 
 
 
 
 
Growthannually 196.17%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.